News

Subject to approval by an EGM, the merger is expected to accelerate Serodus’ commercialisation and development strategy with the addition of two first-in-class drug candidates SER130 and SER140.

Following approval for full marketing authorization from the Italian health authorities in May this year, the company introduced the medicine at reimbursed price, which is same as in

The company has submitted a new drug application for ibrutinib to the FDA that included data from two pivotal Phase 2 studies, one in relapsed/refractory CLL/SLL and one

Available through wholesalers and distributors, as well as directly to the trade, the generic equivalent of ProCentra will be manufactured at Tris’ FDA-inspected facility in Monmouth Junction, New

Working in conjunction with Otsuka Pharmaceutical Europe (OPEL), OEDC will serve as Otsuka’s European research and development headquarters to ensure the successful development and commercialisation of the company’s

Available as a dietary supplement in shot form, the main ingredients of the Pure Recharge Smoothie include whole coffee berry, green coffee bean, Vitamin B12 and gingko biloba.

The affordable, smaller footprint Model 402 makes operation simple with less moving parts, while maintaining the rugged reliability of NJM’s family of labelers. Capable of applying vertical and

The FDA approved patch is currently indicated to provide local dermal analgesia for superficial venous access and superficial dermatological procedures, such as excision, electrodessication and shave biopsy of

Based on the recommendation by the independent Data and Safety Monitoring Board to halt the trial due to safety concerns and lack of efficacy, the company decided to